HIF1A and neoplasm: Specifically, HIF1α deficiency in the tumor endothelium reduces the number of tumor vessels, which reduces tumor growth but increases tumor necrosis; roxarsenical (Rox), an organoarsenic compound, has a significant pro-tumor effect in vivo due to its ability to increase HIF-1α [56, 57].